Abstract
Randomized trials have shown that adenosine diphosphate receptor–blocker drugs such as clopidogrel, which inhibit platelets, prevent adverse cardiovascular (CV) events in patients with acute coronary syndromes. To determine whether smoking status is associated with the efficacy of antiplatelet drugs, researchers undertook a meta-analysis of six studies (74,000 patients with established CV disease, of whom …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
